REWIRING THE ALTERED TRYPTOPHAN METABOLISM AS A NOVEL THERAPEUTIC STRATEGY IN INFLAMMATORY BOWEL DISEASES

Chloe Michaudel  ¹     Camille Danne  ¹     Allison Agus  ²     Aurélie Magniez  ²     Anne Aucouturier  ²     Madeleine Spatz  ²     Antoine Lefevre  ³     Julien Kirchgesner  ⁴     nathalie Rolhion  ⁴     Yazhou Wang  ⁴     Aonghus Lavelle  ⁴     Chloé Galbert  ⁵     Grégory Da Costa  ⁵     Maxime Poirier  ⁵     Alexia Lapiere  ⁵     JULIEN PLANCHAIS  ⁵     Peter Illes  ⁶     Cyriane Oeuvray  ⁶     Marie-Laure Michel  ⁶     Nicolas Benech  ⁶     Anne Bourrier  ⁶     Isabelle Nion Larmurier  ⁶     Cecilia Landman  ⁶     Mathias L. Richard  ⁶     Patrick Emond  ⁶     Philippe Seksik  ⁶     Laurent Beaugerie  ⁶     Rafael Jose Argüello  ⁷     David Moulin  ⁸     Sridhar Mani  ⁹     Zdenek Dvorák  ⁹     Luis Bermudez-Humaran  ⁹     Philippe Langella  ⁹     Harry Sokol  ^9    
1 INRAe, Jouy-en-Josas, France
² Paris Center for Microbiome Medicine (PaCeMM) FHU, Paris, France
³ University of Tours, Tours, France
⁴ Saint-Antoine Hospital - Department of Gastroenterology, Paris, France
⁵ Sorbonne Université, Paris, France
⁶ Palacky University, Olomouc, Czech Republic
⁷ Aix Marseille Univ, Marseille, France
⁸ CNRS, Université de Lorraine, Vandoeuvre-lès-Nancy, France
⁹ Albert Einstein College of Medicine, Bronx, United States

Topic
Disease Mechanisms, IBD, Nurses, Primary Care

Session
New insights in IBD

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)